Oklo Trades at $43. Wall Street's Average Target Is $75. Here's What I Think It's Actually Worth.

Oklo shares trade near $43, down 75% from their $174.14 October 2025 peak, despite Wall Street's roughly $75 average price target. The company achieved criticality at its Groves One pilot reactor after 229 days of construction, but has no commercial reactors or meaningful revenue and does not expect its first Idaho commercial deployments until 2027. Analysts project revenue of $7.9 million in 2027 and $53.3 million in 2028, leaving Oklo valued at roughly 153x projected 2028 sales; the article expects the stock to trade sideways or decline amid valuation and execution risks.

Analysis

OKLO remains a duration asset rather than an operating nuclear utility: its equity value is driven primarily by the probability-weighted timing of licensing, construction, fuel qualification, and contracted power offtake. That creates asymmetric downside if any 2027 milestone slips, because a pre-revenue developer cannot offset a lower terminal multiple with current cash generation. The relevant valuation debate is not whether microreactors address AI power demand, but whether customers will sign financeable, long-duration contracts before substantial dilution is required.

The stronger near-term beneficiaries of data-center power scarcity are likely existing-generation owners and fuel-cycle suppliers, not reactor developers. CEG and VST monetize tight power markets immediately; BWXT has established nuclear manufacturing exposure; LEU offers leverage to HALEU fuel availability, a critical bottleneck for advanced-reactor timelines. A shortage of qualified fuel or slower DOE procurement would impair OKLO’s delivery credibility while potentially improving LEU’s strategic value.

Consensus may be too focused on reactor technical progress and too little on project-finance economics. Small installations can reduce siting friction, but they may carry higher per-MW fixed costs, first-of-a-kind contingencies, insurance requirements, and customer-credit risk; hyperscaler enthusiasm is not equivalent to bankable power purchase agreements. Over the next 1-3 months, high-beta nuclear equities can rally with lower real yields and AI-capex headlines, but the 6-18 month rerating requires disclosed contracted economics, regulatory approvals, and a credible capital plan.

Key Decisions for Investors

• Maintain an underweight/short bias in OKLO only on strength toward consensus-target territory or broad nuclear-theme rallies; use defined-risk put spreads rather than an outright short given retail-driven squeeze risk. A 6-12 month downside thesis is invalidated by a binding, creditworthy long-term PPA plus fully funded construction guidance without material equity dilution.
• Pair long LEU versus short OKLO over 6-12 months: LEU is a cleaner exposure to the advanced-reactor fuel constraint, while OKLO bears execution and financing risk. Size modestly because both remain sensitive to federal HALEU policy and nuclear-sentiment beta.
• For immediate AI-power demand exposure, prefer CEG or VST over pre-commercial reactor developers for the next 1-3 quarters; these names have earnings sensitivity to power pricing rather than binary commercialization milestones. Reassess if wholesale power curves weaken materially or hyperscaler capex guidance rolls over.
• Set an OKLO watch trigger for disclosures of contracted MW, PPA duration and price escalation, expected project capex per MW, and cash runway. Do not upgrade solely on technical or construction milestones unless those disclosures demonstrate returns above the company’s cost of capital.